应对过敏:打击污染和保护我们的健康的策略
Santanu Pattanayak1, Suman Kalyan Dinda1, Shreyasee Hazra1
1Department of Biomedical Science and Technology, School of Biological Sciences, Ramakrishna Mission Vivekananda Educational and Research Institute (RKMVERI), Kolkata, India.
Frontiers in allergy
|January 22, 2025
概括
环境污染物加剧呼吸道和季节性过敏. 通过法规,意识和个人行动解决污染问题对于公共卫生和生态平衡至关重要.
科学领域:
- 环境科学 环境科学
- 过敏和免疫学 过敏和免疫学
- 公共卫生 公共卫生
背景情况:
- 越来越多的证据将环境污染物与过敏反应的增加联系在一起.
- 空气污染 (汽车,工业) 加剧了呼吸道过敏症,如喘.
- 室内污染物 (模具,VOC) 和气候变化 (花粉,天气模式) 也显著引发过敏.
研究的目的:
- 审查环境污染和过敏反应之间的关键联系.
- 为了突出现代社会中污染引起的过敏日益严重的意义.
- 根据环境因素,概述有效的过敏管理策略.
主要方法:
- 最近科学发现的文献综述.
- 分析空气,室内和气候变化相关污染对过敏的影响.
- 综合有关公共卫生和生态影响的信息.
主要成果:
- 环境污染物和过敏反应之间存在强烈的相关性.
- 空气污染加剧了喘和过敏性鼻炎;室内污染物引发了弱势群体的反应.
- 气候变化通过气候变化和花粉增加加剧季节性过敏.
结论:
- 涉及政府,公众和个人努力的全面战略是必不可少的.
- 减轻污染对于降低过敏患病率和保护公共健康至关重要.
- 迫切需要采取行动,以应对日益严重的污染和过敏的挑战.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Drugs Used in Upper Respiratory Disorders: Overview
177
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


